Phoenix water treatment tech startup sold in potentially million dollar plus deal / Phoenix Business Journal
Arbsource, a Phoenix-based company that improves wastewater treatment, has been sold to a New York bio-based renewable energy company in a deal that could top $1 million.
This ASU professor has developed a wearable device to help you chill out / Phoenix Business Journal
Thync, a spin-off from Arizona State University, is marketing a neuroscience-based device that is placed on the head to deliver either calm vibes or a boost of energy selected and controlled from an app on a smartphone.
Arizona SciTech Fest expands with more than 1,000 STEAM events around AZ / Phoenix Business Journal
The fifth annual Arizona SciTech Festival is underway now through March with more than 1,000 events taking place in about 50 cities throughout the state to promote STEM learning and careers.
More than 4,000 entrepreneurs could descend upon Phoenix for the second-annual PHX Startup Week, featuring more than 120 free events ranging from seminars to fireside chats to speakers.
How to keep smart people in Phoenix / Arizona Republic (Op-ed)
As the Valley of the Sun seeks to become a national hub of innovation and entrepreneurship, retaining talented entrepreneurs and their innovative ideas is key.
Billionaire doctor and entrepreneur Patrick Soon-Shiong is pursuing a deal with the city of Phoenix to buy the TGen building at the heart of the Phoenix Biomedical Campus under a long-term lease-purchase agreement. Read also: This biotech billionaire plans bigger expansions in Phoenix
Mayo Clinic in Phoenix has opened a new cancer center linked to its national network which houses a new proton beam therapy program that uses precision targeting to kill tumor cells with positively charged hydrogen atoms.
Non-profits are ‘force to be reckoned with’ in Arizona’s economy / Arizona Republic
Arizona’s growing nonprofit sector is an important economic driver for the state, dominated by big hospitals and other health organizations that make up 56 percent of nonprofit jobs and 62 percent of revenue.
Tucson firm to test drug for sickle-cell complications / Arizona Daily Star
NuvOx Pharma, a Tucson-based drug development company, has won federal approval for a clinical trial to test one of its drug candidates to treat complications from sickle cell disease.
The University of Arizona College of Science is receiving a $1 million endowment to support the school in the areas of chemistry, biochemistry, and mathematics.
Phoenix Children’s Hospital is a primary member of the Pediatrics Consortium of Cancer MoonShot 2020, a national coalition of private and public partners led by Dr. Patrick Soon-Shiong to enhance cancer treatments.
At the University of Arizona, researchers are trying to modify mosquitos to resist infectious diseases such as malaria and then release these resistant mosquitos with the goal of replacing wild populations that transmit disease.